Compare PLETHICO PHARMA with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA UNICHEM LAB PLETHICO PHARMA/
UNICHEM LAB
 
P/E (TTM) x -1.1 61.3 - View Chart
P/BV x 0.0 0.7 2.5% View Chart
Dividend Yield % 0.0 2.1 -  

Financials

 PLETHICO PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
UNICHEM LAB
Mar-19
PLETHICO PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs395292 135.2%   
Low Rs31182 17.2%   
Sales per share (Unadj.) Rs604.4167.7 360.5%  
Earnings per share (Unadj.) Rs32.5-3.6 -894.6%  
Cash flow per share (Unadj.) Rs51.35.9 863.8%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %01.7 0.0%  
Book value per share (Unadj.) Rs473.6372.3 127.2%  
Shares outstanding (eoy) m34.0870.38 48.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.41.4 24.9%   
Avg P/E ratio x6.6-65.3 -10.1%  
P/CF ratio (eoy) x4.239.9 10.4%  
Price / Book Value ratio x0.50.6 70.7%  
Dividend payout %0-110.2 0.0%   
Avg Mkt Cap Rs m7,26216,680 43.5%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m1,5962,393 66.7%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m20,59811,801 174.6%  
Other income Rs m386984 39.3%   
Total revenues Rs m20,98412,785 164.1%   
Gross profit Rs m2,818-835 -337.5%  
Depreciation Rs m642674 95.3%   
Interest Rs m1,59375 2,118.6%   
Profit before tax Rs m969-600 -161.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138-343 40.3%   
Profit after tax Rs m1,107-256 -433.2%  
Gross profit margin %13.7-7.1 -193.3%  
Effective tax rate %-14.357.3 -24.9%   
Net profit margin %5.4-2.2 -248.2%  
BALANCE SHEET DATA
Current assets Rs m18,87720,384 92.6%   
Current liabilities Rs m11,8965,029 236.5%   
Net working cap to sales %33.9130.1 26.0%  
Current ratio x1.64.1 39.1%  
Inventory Days Days36105 34.3%  
Debtors Days Days198135 146.7%  
Net fixed assets Rs m9,8619,023 109.3%   
Share capital Rs m341141 242.0%   
"Free" reserves Rs m12,33126,058 47.3%   
Net worth Rs m16,13926,199 61.6%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14631,496 105.2%  
Interest coverage x1.6-7.0 -23.1%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.4 165.9%   
Return on assets %8.1-0.6 -1,422.8%  
Return on equity %6.9-1.0 -703.2%  
Return on capital %12.3-2.0 -614.7%  
Exports to sales %21.469.4 30.8%   
Imports to sales %15.20-   
Exports (fob) Rs m4,4028,188 53.8%   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,4028,188 53.8%   
Fx outflow Rs m3,184596 534.2%   
Net fx Rs m1,2197,592 16.0%   
CASH FLOW
From Operations Rs m2,437-3,278 -74.4%  
From Investments Rs m-6,265-2,860 219.0%  
From Financial Activity Rs m2,490-24 -10,289.7%  
Net Cashflow Rs m-1,337-4,690 28.5%  

Share Holding

Indian Promoters % 82.7 50.1 165.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 15.1 28.5%  
FIIs % 5.5 3.0 183.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 31.7 23.7%  
Shareholders   10,665 20,176 52.9%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  WYETH LTD  GSK PHARMA  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - J.B.CHEMICALS COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS